openPR Logo
Press release

Meridian Purchases Medical Office Building in Tucson, Arizona

10-21-2024 07:08 PM CET | Industry, Real Estate & Construction

Press release from: ABNewswire

Meridian plans to invest significant capital into renovations and upgrades immediately. Once completed, the property will be fully occupied by El Rio Health, a Federally Qualified Health Center (FQHC) that has provided comprehensive, accessible, and affor

Meridian plans to invest significant capital into renovations and upgrades immediately. Once completed, the property will be fully occupied by El Rio Health, a Federally Qualified Health Center (FQHC) that has provided comprehensive, accessible, and affor

TUCSON, Ariz. - Meridian, a full-service real estate developer and owner of medical real estate, is pleased to announce that the firm has closed escrow on the purchase of a vacant 94,569-square-foot medical building in Tucson, Arizona, located at 4888 N. Stone Avenue on a 9.27-acre parcel. The property will be fully occupied by El Rio Health, a Federally Qualified Health Center (FQHC) that has provided comprehensive, accessible, and affordable healthcare to the Tucson community for 54 years.

Meridian is recognized nationally for its expertise in repositioning defunct buildings into high-performance medical properties. Meridian plans to invest significant capital into renovations and upgrades immediately. The former inpatient cardiovascular hospital, which has been vacant for 15 years, will be converted into a state-of-the-art health center. In addition, the project plans to install Class A custom tenant improvements that are fully designed to meet El Rio Health's service line needs. Construction is estimated to begin later this month, with completion anticipated in early 2026. "El Rio Health was looking for a strategic solution to address the growing demand for primary healthcare services in Tucson," said Sheila Schmidt-Turkington, Managing Director of Strategy and Development at Meridian. "We were thrilled to work with El Rio leadership and their broker, Rick Kleiner, Principal, Cushman & Wakefield | PICOR, to identify a location that was already entitled for medical use for speed to market. This location is strategically positioned to increase access to care for El Rio Health's patient base."

Schmidt-Turkington added, "Early collaboration with El Rio Health and Cushman & Wakefield | PICOR enabled Meridian to negotiate a favorable purchase price and ensure a turnkey construction solution. The deal structure provides a flexible option for El Rio Health to own the real estate, granting them financial flexibility customized to meet their needs. This approach mitigated capital constraints while positioning El Rio Health for further growth in Tucson. It's truly an honor to help El Rio Health realize its ambulatory goals. El Rio provides care to 1 in 9 people in Tucson."

The central utility plant has not been functional for many years, so Meridian will decommission the outdated equipment and install new systems tailored to El Rio Health's specific needs. The building will also feature a new parking lot to provide five spaces for every 1,000 square feet, plus new water-efficient landscaping. Additionally, it will receive a new roof, HVAC units, boilers, and fire sprinkler system. The interior will be completely demolished to a cold shell, allowing for an entirely new code-compliant, energy-efficient facility designed to maximize patient experience and throughput. This revitalization will provide El Rio Health with a modern, functional, and patient-centric environment that enhances both care delivery and operational efficiency.

"El Rio Health is a trusted healthcare provider in Tucson," said Meridian CEO, Mike Conn. "They have served the community for over 50 years, currently operating 14 health centers and providing care for more than 128,000, approximately 10% of Tucson's population. This new facility will enable El Rio Health to expand services and meet the increasing demand for timely healthcare access. We could not be more excited to work with a non-profit organization that aligns so perfectly with our own mission - to provide greater access to care at a more affordable cost."

"We are thrilled with Meridian's ability to deliver a facility that meets our current needs and future growth plans," said Clinton Kuntz, DBH, CEO of El Rio Health. "This new location is ideally situated to serve patients from multiple Tucson areas while alleviating capacity stress at our current Prince Road health center. We intend to offer a full range of our service lines at this location, including primary medical, dental and behavioral health care, pharmacy, radiology, specialized care and support services. This partnership ensures we can continue to meet the growing needs for primary care, and we are eager to begin construction."

Conn added, "This acquisition exemplifies Meridian's ability to partner together on real estate challenges with creative solutions that address capital constraints and the urgent need for expanded access to healthcare. Our adaptive reuse approach fosters speed to market at a lower cost, while providing flexible ownership options."

Rick Kleiner [https://www.picor.com/richard-m-kleiner/] of Cushman & Wakefield | PICOR represented Meridian on the acquisition and El Rio Health on the lease. Vince Femiano and Kate Morris of Transwestern represented the seller, an affiliate of Tenet Health, in the sale.

About El Rio Health

El Rio Health is the largest provider of medical and dental services for the uninsured and Medicaid populations in Pima County. El Rio serves the medical, dental, and behavioral health needs of over 128,000 patients annually. El Rio employs over 1,900 people with an annual budget of over $255 million dollars. A national model of health care excellence, El Rio's mission is to "improve the health of our community through comprehensive, accessible, affordable, quality and compassionate care." www.elrio.org [https://elrio.org/].

About Meridian

Founded in 1999, Meridian is a full-service real estate developer and investor specializing in high-quality, brand-enhancing healthcare and life science developments. The firm owns and manages healthcare properties throughout the United States and continues to aggressively pursue acquisitions and developments.

Meridian focuses on solving real estate challenges for healthcare providers and systems, including opportunistic repurposing, value-add, core-plus, and build-to-suit projects across the continuum of care. Additionally, Meridian offers development and construction management services for entities seeking to retain ownership from project inception. Its services are broad in scope but meticulous in detail, covering everything from site evaluation and land acquisition to entitlement, planning, and construction management. For more information, see www.mpcca.com [https://mpcca.com/].

Media Contact
Company Name: Meridian
Contact Person: Rachel Schell, Senior Manager of Marketing and Operations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=meridian-purchases-medical-office-building-in-tucson-arizona]
Phone: (925) 302-1400
Address:500 Ygnacio Valley Road Suite 325
City: Walnut Creek
State: California
Country: United States
Website: https://mpcca.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Meridian Purchases Medical Office Building in Tucson, Arizona here

News-ID: 3702967 • Views:

More Releases from ABNewswire

The Journey of Scoopearth to Scoopearth.in - A Startup Media Revolution
The Journey of Scoopearth to Scoopearth.in - A Startup Media Revolution
In a bold and strategic move, Scoopearth [https://scoopearth.in/], one of India's most trusted startup media platforms, has officially transitioned from Scoopearth.com to Scoopearth.in. This evolution marks a new chapter in the company's journey toward becoming a leading hub for startup stories, business insights, entrepreneurial news and Podcast. Founded by Niraj Kumar, Deepika Khare and Anamika Sinha, Scoopearth has been at the forefront of startup journalism, delivering high-value content that inspires, educates,
Hepatitis A Market Outlook: Strong Pipeline, Strategic Collaborations, and Increasing Public Health Investments | DelveInsight
Hepatitis A Market Outlook: Strong Pipeline, Strategic Collaborations, and Incre …
The Hepatitis A market is projected to experience robust growth, fueled by the launch of innovative therapies, rising disease prevalence, and heightened healthcare investments across key regions. Industry leaders, including Boryung Pharmaceutical, Cadila Healthcare, Indian Immunologicals, Biological E Limited, Sinovac Biotech Co., Ltd, Sanofi, GlaxoSmithKline, Crucell Holland BV, and Merck, among others, are at the forefront of research and development initiatives in this therapeutic area. DelveInsight's latest report titled "Hepatitis A
Phenylketonuria Market Growth Accelerates With SEPHIENCE FDA Approval and Promising Late-Stage Clinical Advances | DelveInsight
Phenylketonuria Market Growth Accelerates With SEPHIENCE FDA Approval and Promis …
DelveInsight's comprehensive Phenylketonuria Market Insight, Epidemiology and Market Forecast - 2034 report provides crucial intelligence for pharmaceutical companies, investors, and healthcare stakeholders navigating the evolving Phenylketonuria therapeutic landscape. Key Takeaways and Recent Developments * Phase 3 APHENITY Trial Data Reveal Robust Diet Liberalization: In March 2025, PTC Therapeutics presented new APHENITY results showing that 97% of participants in the open-label extension were able to liberalize their diet while on sepiapterin treatment, with
Myasthenia Gravis Landscape: Regeneron's NIMBLE Trial Success with Cemdisiran, First Complement C5 siRNA Therapy | DelveInsight's Perspective on Market, Competitive Landscape and Pipeline Impact
Myasthenia Gravis Landscape: Regeneron's NIMBLE Trial Success with Cemdisiran, F …
DelveInsight's latest analysis highlights the transformative potential of Regeneron Pharmaceuticals' positive Phase 3 NIMBLE trial results for cemdisiran in generalized myasthenia gravis (gMG). This landmark achievement marks a significant advancement in complement inhibition therapy, offering new hope for patients suffering from this chronic autoimmune neuromuscular disorder characterized by muscle weakness and rapid fatigue due to disrupted communication at the neuromuscular junction. DelveInsight Business Research's latest analysis highlights the transformative potential of

All 5 Releases


More Releases for Health

Health Coach Market Positioned for Accelerated Growth with Iora Health, Virta He …
Global health coach market is estimated to be valued at USD 18.83 Bn in 2025 and is expected to reach USD 30.65 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032. Latest Report on the Health Coach Market 2025-2032, focuses on a comprehensive analysis of the current and future prospects of the Health Coach Market industry. An in-depth analysis of historical trends, future trends,
Digital Therapeutics Market Research 2025 Leading Key Players - Proteus Digital …
An exclusive Digital Therapeutics Market research report created through broad primary research (inputs from industry experts, companies, and stakeholders) and secondary research, the report aims to present the analysis of Global Digital Therapeutics Market by Type, By Application, By Region - North America, Europe, South America, Asia-Pacific, Middle East and Africa. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report
Digital Therapeutics Market Outlook 2025 : Proteus Digital Health, Omada Health, …
ReportsWeb.com has announced the addition of the “Global Digital Therapeutics Market Size, Status and Forecast 2025” The report focuses on major leading players with information such as company profiles, product picture and specification. This report studies the global Digital Therapeutics market, analyzes and researches the Digital Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market,
Digital Therapeutics Market Outlook to 2025 - Propeller Health, CANARY HEALTH, N …
The global digital therapeutics market is segmented on the basis of application, distribution channel, and geography. The application segment includes, respiratory diseases, central nervous system disease, smoking cessation, medication adherence, cardiovascular diseases, musculoskeletal diseases, and other applications. Based on distribution channel, the digital therapeutics market is segmented as, B2B and B2C. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and
Digital Therapeutics Market Analysis 2018 | Growth by Top Companies: Proteus Dig …
Global Digital Therapeutics Market to 2025 This report "Digital Therapeutics Market Analysis to 2025" provides an in-depth insight of medical device industry covering all important parameters including development trends, challenges, opportunities, key manufacturers and competitive analysis. Digital therapeutics, a subset of digital health, is a health discipline and treatment option that utilizes a digital and often online health technologies to treat a medical or psychological condition. The treatment relies on behavioral and
Digital Therapeutics Market Global Outlook to 2025 - Proteus Digital Health, Wel …
“Digital Therapeutics Market" covers a detailed research on the industry with financial analysis of the major players. The report provides key information and detailed study relating to the industry along with the Economic Impact and Regulatory and Market Support. The report examines the industry synopsis, strategic investments, Industry Surveys, Economic Impact, etc. The market of digital therapeutics market is anticipated to grow with a significant rate in the coming years, owing